⌘K

Login Start Free

Home/Filings/4/0001209191-21-070273

4//SEC Filing

Salter Malcolm 4

Accession 0001209191-21-070273

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:28 PM ET

Size

4.7 KB

Accession

0001209191-21-070273

Insider Transaction Report

Form 4

Period: 2021-12-17

C4 Therapeutics, Inc.CCCC

Director

Transactions

Sale
Common Stock
2021-12-17$30.25/sh−755$22,839→ 10,952 total

Footnotes (1)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001825124

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 4:28 PM ET
Size: 4.7 KB

View on SEC.gov